News

  • News Archive
23 October 2012

Cobra Biologics’ Growth Is Strengthened

04 September 2012

Cobra Biologics and Algeta Sign Agreement to Manufacture Monoclonal Antibody

26 June 2012

Cobra Biologics and KAHR Medical extend their partnership to develop both KAHR-101 and KAHR-102

12 June 2012

Cobra Biologics and Alligator Bioscience AB Sign Monoclonal Antibody Manufacturing Agreement

29 February 2012

Cobra Biologics Wins Manufacturing Agreement to Produce Anaerobic Bacteria

13 February 2012

Cobra Biologics’ Expansion Continues

For further information, please contact:

Julian Hanak
Commercial Services
Tel: +44 (0) 1782 714 181

   

 

News Alert

View privacy policy